The suggestion that the three X linked syndromes X linked spastic paraplegia (MIM 312900) 
at Xq28 was confirmed by the finding of mutations in the LI-CAM gene in the three syndromes. Recently, two families in which different subjects showed a clearly different phenotype within the same family of the three X linked syndromes were described. A reverse transcription PCR assay was developed for the analysis ofthe LI-CAM cDNA in two of the members of these families. RNA isolated from EBV transformed cell lines and a colon carcinoma derived cell line was used as a starting material. The Li-CAM cDNA of two male patients from each family was sequenced. We report two new mutations in the LI-CAM gene in these two families showing that the three different phenotypes observed in different generations within the same family are variable phenotypic expressions of the same mutation.
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* Nested biotinylated primer.
t FITC labelled sequencing primers. To identify the mutation in other subjects a dot blot assay was performed using an end labelled oligonucleotide containing the mutated sequence or the wild type sequence as a probe (table 1B) . PCR products containing exons 4, 5, and 6 for mutation I179S, and PCR products containing exons 8, 9, and 10 for mutation G370R (table 2) were used in the dot blot procedure. After hybridisation with the labelled probe, a stringent wash was performed in 2 x SSC/0-5% SDS at 55°C for 10 minutes.
Results
In all the subjects analysed and in the control cell line several differences from the published sequence ofthe LI -CAM gene were detected." A 15 bp deletion was found at coding position 97 of the cDNA compared to the published sequence and a 12bp deletion at bp3551. The latter has already been described as an alternative splicing form of Li-CAM. 12 The deletion at bp 97 might therefore also be the result of an alternative splicing event in white blood cells. At nucleotide position 875 a T to Mutations in Li-CAM in two families with X linked complicated spastic paraplegia, MASA syndrome, and HSAS detected. Dot blot analyses of genomic DNA of the other members of the family showed that the mutation segregated in all female carriers (II-3, IIIl,1,III9, IV-5, IV-6, and IV-8) as determined previously by linkage analysis,8 and all affected males (II-5, spastic gait and borderline intelligence; III3, spastic paresis, mentally retarded, and adducted thumbs; III8 spastic paresis without involvement of the thumbs). A different point mutation was found in the two patients of family 2 (fig 2) , a G to A transversion at nucleotide position 1128 of the Li-CAM gene sequence, resulting in the change of glycine into arginine at position 370 of the amino acid sequence (G370R) (fig 4) .
In family 2 the mutation G370R was detected by dot blot analysis of genomic DNA in the two partially expressing females (samples 6 and 30), in all obligate female carriers (samples 10, 13, 20, 26, and 51), in the females predicted to be carriers by linkage analysis (samples 45, 53, 54, and 62), and all the affected males (samples 16 C transition was observed, which at the protein level would be a silent mutation, and an insertion of a cytosine at nucleotide position 3806 within the 3' untranslated region of the Li-CAM transcript was detected.
In the two patients of family 1 (fig 1) a T to G transition at nucleotide position 556, resulting in a change of isoleucine into serine at amino acid position 179 (1179S) (fig 3) , was Discussion LI-CAM belongs to the immunoglobulin superfamily of proteins. These proteins can be structurally divided into three segments: (1) an extracellular portion consisting of six immunoglobulin-like (Ig) domains and five fibronectin III (Frn) domains,'415 (2) a transmembrane domain, and (3) a cytoplasmic domain.
We present here two new mutations in the LI-CAM gene in affected subjects from two different families: an I179S mutation located within the loop ofthe first Ig-like domain ofL1 -CAM and a G370R mutation located within the fourth Ig-like domain. Dot blot analyses showed that neither of the mutations were polymorphisms found in the general population and confirmed that they segregated with the clinical syndrome. Moreover, hybridisation to both the mutated oligonucleotide and the wild type oligonucleotide showed the presence of one affected and one normal allele in all carrier females.
It is interesting to note that these mutations were observed in affected subjects from two families where we observed the three syndromes, complicated spastic paraplegia, MASA syndrome, and X linked hydrocephalus owing to stenosis of the aqueduct of Sylvius as apparent variable expression of mutations at the same locus at Xq28.8913 All the reports published so far identified mutations in the Li-CAM gene in families with one of the three phenotypes. These data further illustrate the fact that the three clinical entities are phenotypic variants of the same genetic defect and not separate entities, as originally suggested by Straussberg et al. '6 The finding of a single point mutation in each of the members of the same family with variable clinical phenotypes suggests that the phenotypic expression of the Li-CAM gene is influenced by other genetic or environmental factors. This observation may then explain the absence ofa definitive phenotype-genotype correlation in these X linked syndromes.
